INFANRIX-IPV+HIB

Powder and suspension for suspension for injection, 30i.j./0.5ml + 40i.j./0.5ml + 25mcg/0.5ml + 25mcg/0.5ml + 8mcg/0.5ml + 40D.j./0.5ml + 8D.j./0.5ml + 32D.j./0.5ml + 10mcg PRP/0.5ml i približno 25mcg T/0.5ml

RxActive license

Active substance (INN)

diphtheria, tetanus, pertussis (acellular), poliomyelitis (inactivated) and Haemophilus influenzae type b (conjugate, adsorbed) vaccine, combined

Pharmaceutical form

Pharmaceutical formPowder and suspension for suspension for injection

Strength30i.j./0.5ml + 40i.j./0.5ml + 25mcg/0.5ml + 25mcg/0.5ml + 8mcg/0.5ml + 40D.j./0.5ml + 8D.j./0.5ml + 32D.j./0.5ml + 10mcg PRP/0.5ml i približno 25mcg T/0.5ml

PackagingUkupno 1 bočica sa praškom i 1 napunjeni injekcioni špric sa 0.5ml suspenzije (sa 2 igle) u kartonskoj kutiji

ManufacturerGlaxoSmithKline Biologicals S.A., Belgium

Therapeutic groupAnti-infectives for systemic use (J07CA06)

Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA

Authorization dateNovember 11, 2025

Source: CInMED register